Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celanese (CE) Capital Expenditures (2016 - 2025)

Celanese's Capital Expenditures history spans 17 years, with the latest figure at $84.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 20.0% year-over-year to $84.0 million; the TTM value through Dec 2025 reached $343.0 million, down 21.15%, while the annual FY2025 figure was $343.0 million, 21.15% down from the prior year.
  • Capital Expenditures reached $84.0 million in Q4 2025 per CE's latest filing, up from $64.0 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $304.0 million in Q3 2021 to a low of $64.0 million in Q3 2025.
  • Average Capital Expenditures over 5 years is $126.1 million, with a median of $124.0 million recorded in 2022.
  • The largest YoY upside for Capital Expenditures was 48.91% in 2022 against a maximum downside of 54.28% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at $304.0 million in 2021, then tumbled by 52.96% to $143.0 million in 2022, then dropped by 10.49% to $128.0 million in 2023, then dropped by 17.97% to $105.0 million in 2024, then decreased by 20.0% to $84.0 million in 2025.
  • Per Business Quant, the three most recent readings for CE's Capital Expenditures are $84.0 million (Q4 2025), $64.0 million (Q3 2025), and $93.0 million (Q2 2025).